Relative Expression of Wild-Type and Activated Ki-Ras2 Oncogene in Colorectal Carcinomas

International Journal of Oncology - Greece
doi 10.3892/ijo.3.5.841
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Ki-67, P53, BCL-2 and Bax Expression in Urothelial Carcinomas of Urinary Bladder

Turk Patoloji Dergisi
Forensic MedicinePathology
2010English

Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions

Cancer Research
Cancer ResearchOncology
2019English

Expression of Ki-67 and P16 INK4a in Chemically-Induced Perioral Squamous Cell Carcinomas in Mice.

Revista do Colegio Brasileiro de Cirurgioes
Surgery
2016English

SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas

PLoS ONE
Multidisciplinary
2010English

FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer

World Journal of Surgical Oncology
SurgeryOncology
2018English

Altered mRNA Expression of Glycosyltransferases in Human Colorectal Carcinomas and Liver Metastases

Gut
Gastroenterology
2000English

Prognostic Significance of TRAIL-R1 and TRAIL-R3 Expression in Metastatic Colorectal Carcinomas

European Journal of Cancer
Cancer ResearchOncology
2008English

Development of Keratoacanthomas and Squamous Cell Carcinomas in Transgenic Rabbits With Targeted Expression of EJras. Oncogene in Epidermis

American Journal of Pathology
Forensic MedicinePathology
1999English

The Prognostic Significance of Serum CA125 Levels With ER, PR, P53 and Ki-67 Expression in Endometrial Carcinomas

Ginekologia Polska
GynecologyObstetrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy